SIEBERT FINANCIAL CORP
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
SIEB$1.810.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Three Months Ended March 31, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash Flows From Operating Activities | ||
| Net income (loss) | $(1,972,000) | $8,661,000 |
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Deferred tax expense (benefit) | (941,000) | 777,000 |
| Depreciation and amortization | 690,000 | 415,000 |
| Goodwill impairment | 330,000 | — |
| Intangible asset impairment | 454,000 | — |
| Loss on disposal of assets | 83,000 | — |
| FMR clearing arrangement (1) | 100,000 | — |
| Share-based compensation (2) | 832,000 | 554,000 |
| Interest related to contract termination liability payment | 86,000 | 50,000 |
| Changes in | ||
| Securities segregated for regulatory purposes | (3,178,000) | 24,389,000 |
| Receivables from customers | (4,483,000) | 4,791,000 |
| Receivables from non-customers | (114,000) | (195,000) |
| Receivables from and deposits with broker-dealers and clearing organizations | (6,508,000) | (2,223,000) |
| Securities borrowed | 151,703,000 | (68,551,000) |
| Securities owned, at fair value | (192,000) | (7,979,000) |
| Notes receivable | (2,000,000) | — |
| Prepaid expenses and other assets | (272,000) | (623,000) |
| Payables to customers | (7,884,000) | (20,207,000) |
| Payables to non-customers | (1,000) | (641,000) |
| Drafts payable | (461,000) | (276,000) |
| Payables to broker-dealers and clearing organizations | (254,000) | 847,000 |
| Accounts payable and accrued liabilities | 1,368,000 | (430,000) |
| Securities loaned | (152,690,000) | 25,726,000 |
| Securities sold, not yet purchased, at fair value | (69,000) | 116,000 |
| Net lease liabilities | (33,000) | (4,000) |
| Taxes payable / receivable | 46,000 | 1,058,000 |
| NFS business development credits | (240,000) | (213,000) |
| Other deferred revenue | (5,000) | — |
| Contract termination liability payment | (500,000) | (503,000) |
| Net cash used in operating activities | (26,105,000) | (34,461,000) |
| Cash Flows From Investing Activities | ||
| Purchase of office facilities and equipment | (67,000) | (63,000) |
| Purchase of software | (286,000) | (940,000) |
| Additions to property, office facilities, and equipment | (103,000) | (144,000) |
| Cash paid in investments at cost | (520,000) | — |
| Net cash used in investing activities | (976,000) | (1,147,000) |
| Cash Flows From Financing Activities | ||
| RISE cash distribution | — | (35,000) |
| Repayments of long-term debt | (23,000) | (23,000) |
| Net cash used in financing activities | (23,000) | (58,000) |
| Net change in cash and cash equivalents, and cash segregated for regulatory purposes | (27,104,000) | (35,666,000) |
| Cash and cash equivalents, and cash segregated for regulatory purposes - beginning of period | 173,415,000 | 168,458,000 |
| Cash and cash equivalents, and cash segregated for regulatory purposes - end of period | $146,311,000 | $132,792,000 |
| Reconciliation of cash, cash equivalents, and cash segregated for regulatory purposes | ||
| Cash and cash equivalents - end of period | 16,157,000 | 25,713,000 |
| Cash segregated for regulatory purposes - end of period | 130,154,000 | 107,079,000 |
| Cash and cash equivalents, and cash segregated for regulatory purposes - end of period | $146,311,000 | $132,792,000 |
| Supplemental cash flow information | ||
| Cash paid during the period for income taxes | $— | $— |
| Cash paid during the period for interest | $132,000 | $39,000 |
| (1) | Refer to Note 1 – Organization and Basis of Presentation |
| (2) | Refer to Note 20 – Employee Benefit Plans for further detail. |
-4 -
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.